Initially, an online database was utilized to assess mRNA expression levels of PARP9 across different tumor types, followed by an analysis of its expression in TCGA-STAD, ultimately revealing that elevated PARP9 levels correlate with poor prognosis in GC patients. Here, PARP9 is linked to gastric cancer.